Luis Peña, Evommune CEO

Evom­mune rais­es $50M to fund clin­i­cal tri­als in skin dis­eases

Evom­mune has raised a $50 mil­lion fund­ing round that it plans to use to bankroll a se­ries of clin­i­cal tri­als over …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.